Eagle Bay Advisors LLC Pmv Pharmaceuticals, Inc. Transaction History
Eagle Bay Advisors LLC
- $121 Million
- Q2 2025
A detailed history of Eagle Bay Advisors LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 234 shares of PMVP stock, worth $280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
234Holding current value
$280% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PMVP
# of Institutions
63Shares Held
40.4MCall Options Held
1.8KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$7.77 Million0.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.75MShares$4.5 Million3.31% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$4.48 Million1.53% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.31MShares$3.97 Million0.07% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.3MShares$3.96 Million0.29% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $54.7M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...